Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to treat depression and several anxiety-related disorders, but there are some beliefs surrounding them that aren’t true [1,2].
We partnered with @CAMHNews to debunk some common myths around SSRIs. While they might not be for everyone, it’s important to make medication decisions based on good information and facts.
Sources
- Antidepressant Medications: Information for Patients | CAMH
- Selective Serotonin Reuptake Inhibitors | StatPearls – NCBI Bookshelf | May 2023
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults | Canadian Network for Mood and Anxiety Treatments (CANMAT) | 2024
- Depression | CAMH
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis | JAMA Psychiatry – Archives of General Psychiatry | November 2006
- A Meta-Analysis of Early Sustained Response Rates Between Antidepressants and Placebo for the Treatment of Major Depressive Disorder | Journal of Clinical Psychopharmacology | February 2006
- Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis | Journal of Psychiatric Research | November 2017
- Selective serotonin reuptake inhibitors (SSRIs) | NHS inform
- Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study | The British Journal of Psychiatry | January 2018
Share our original Bluesky Post!
View our original Instagram Post!
